Cost-effectiveness analysis of tranexamic acid for the treatment of traumatic brain injury, based on the results of the CRASH-3 randomised trial: a decision modelling approach. (2020)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjgh-2020-002716
PubMed Identifier: 32878899
Publication URI: http://europepmc.org/abstract/MED/32878899
Type: Journal Article/Review
Volume: 5
Parent Publication: BMJ global health
Issue: 9
ISSN: 2059-7908